La Lingua Nostra La Lingua Nostra
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Registrati
    Iscriviti
    Cerca
    Night Mode

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • EXPLORE
  • Pagine
  • Gruppi
  • Events
  • Blogs
  • Offers
  • Jobs
  • Articoli
  • Articles
  • Utenti
  • Pagine
  • Gruppi
  • Events
  • ROHIT GAURYA ha aggiunto un file Health
    2026-04-08 09:52:39 -
    Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
    According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...
    0 Commenti 0 condivisioni 30 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • ROHIT GAURYA ha aggiunto un file Health
    2026-03-18 09:46:28 -
    Meningococcal Polysaccharide Vaccine Market to Reach USD 4.5 Billion by 2030 | CAGR 6.3%
        According to a newly published market research report by 24LifeSciences, global meningococcal polysaccharide vaccine market was valued at USD 2.8 billion in 2023 and is projected to reach USD 4.5 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2024-2030. Meningococcal polysaccharide vaccines are immunogenic preparations...
    0 Commenti 0 condivisioni 236 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Rohit Katkam ha aggiunto un file Altre informazioni
    2026-04-01 10:05:46 -
    Nucleic Vaccine Market Growth Report 2034: Rising at 2.8% CAGR with Expanding Therapeutic Applications
    According to a new report from Intel Market Research, the global Nucleic Vaccine market was valued at USD 49.34 billion in 2024 and is projected to reach USD 59.64 billion by 2034, growing at a CAGR of 2.8% during the forecast period. This growth reflects the transformative impact of mRNA vaccine technology, particularly evident in the rapid response to the COVID-19 pandemic, alongside...
    0 Commenti 0 condivisioni 149 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2026 La Lingua Nostra Italiano
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termini e Condizioni Privacy Contattaci